0.04 ml semaglutide Dosage Guide for Weight Loss Canada approves first generic version

Dehydration and insufficient calorie intake amplify fatigue and dizziness regardless of injection technique

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial

The National Institute for Health and Care Excellence (NICE) provides guidance on the appropriate use of GLP-1 receptor agonists in diabetes management

Current evidence suggests that exposure through breast milk is unlikely to harm infants, but individual risk assessment is warranted

Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade